These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36709328)

  • 21. Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer.
    Liu JS; Fang WK; Yang SM; Wu MC; Chen TJ; Chen CM; Lin TY; Liu KL; Wu CM; Chen YC; Chuu CP; Wang LY; Hsieh HP; Kung HJ; Wang WC
    J Biomed Sci; 2022 May; 29(1):29. PubMed ID: 35534851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosstalk of NF-κB/P65 and LncRNA HOTAIR-Mediated Repression of MUC1 Expression Contribute to Synergistic Inhibition of Castration-Resistant Prostate Cancer by Polyphyllin 1-Enzalutamide Combination Treatment.
    Xiang S; Zou P; Wu J; Zheng F; Tang Q; Zhou J; Hann SS
    Cell Physiol Biochem; 2018; 47(2):759-773. PubMed ID: 29807357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of phospholipase Cε knockdown with GANT61 sensitizes castration‑resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway.
    Sun W; Li L; Du Z; Quan Z; Yuan M; Cheng H; Gao Y; Luo C; Wu X
    Oncol Rep; 2019 May; 41(5):2689-2702. PubMed ID: 30864728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
    Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
    Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis.
    Zou P; Chen Z; He Q; Zhuo Y
    Prostate; 2024 Jan; 84(1):64-73. PubMed ID: 37750290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer.
    Nelius T; Martinez-Marin D; Hirsch J; Miller B; Rinard K; Lopez J; de Riese W; Filleur S
    Cell Death Dis; 2014 May; 5(5):e1210. PubMed ID: 24810046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S100A3 suppression inhibits in vitro and in vivo tumor growth and invasion of human castration-resistant prostate cancer cells.
    Kang M; Lee HS; Lee YJ; Choi WS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
    Urology; 2015 Jan; 85(1):273.e9-15. PubMed ID: 25440760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer.
    Naiki T; Naiki-Ito A; Asamoto M; Kawai N; Tozawa K; Etani T; Sato S; Suzuki S; Shirai T; Kohri K; Takahashi S
    Carcinogenesis; 2014 Sep; 35(9):1962-7. PubMed ID: 24562575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo.
    Mapoung S; Suzuki S; Fuji S; Naiki-Ito A; Kato H; Yodkeeree S; Ovatlarnporn C; Takahashi S; Limtrakul Dejkriengkraikul P
    Cancer Sci; 2019 Feb; 110(2):596-607. PubMed ID: 30499149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro.
    Du Z; Li L; Sun W; Wang X; Zhang Y; Chen Z; Yuan M; Quan Z; Liu N; Hao Y; Li T; Wang J; Luo C; Wu X
    Int J Oncol; 2018 Jul; 53(1):99-112. PubMed ID: 29658567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.
    Hu X; Garcia C; Fazli L; Gleave M; Vitek MP; Jansen M; Christensen D; Mulholland DJ
    Sci Rep; 2015 Nov; 5():15182. PubMed ID: 26563471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of protein S in castration-resistant prostate cancer-like cells.
    Ning P; Zhong JG; Jiang F; Zhang Y; Zhao J; Tian F; Li W
    Endocr Relat Cancer; 2016 Aug; 23(8):595-607. PubMed ID: 27342144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer.
    Zhang H; Zhou Y; Feng Y; Hou W; Chen Y; Xing Z; Zhang Y; Wei Q; Yin Y; Guo J; Hu H
    Clin Transl Med; 2024 May; 14(5):e1678. PubMed ID: 38736108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.
    Moon SJ; Jeong BC; Kim HJ; Lim JE; Kim HJ; Kwon GY; Jackman JA; Kim JH
    Theranostics; 2021; 11(2):958-973. PubMed ID: 33391515
    [No Abstract]   [Full Text] [Related]  

  • 35. Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.
    Zhao N; Peacock SO; Lo CH; Heidman LM; Rice MA; Fahrenholtz CD; Greene AM; Magani F; Copello VA; Martinez MJ; Zhang Y; Daaka Y; Lynch CC; Burnstein KL
    Sci Transl Med; 2019 Jun; 11(498):. PubMed ID: 31243151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β-catenin signaling.
    Chen Z; Zhou L; Wang L; Kazobinka G; Zhang X; Han X; Li B; Hou T
    Mol Carcinog; 2018 Jan; 57(1):12-21. PubMed ID: 28796367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate.
    Han J; Lachance C; Ricketts MD; McCullough CE; Gerace M; Black BE; Côté J; Marmorstein R
    J Biol Chem; 2018 Mar; 293(12):4498-4509. PubMed ID: 29382722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis.
    Xiao L; Wang Y; Xu K; Hu H; Xu Z; Wu D; Wang Z; You W; Ng CF; Yu S; Chan FL
    Cancer Res; 2018 May; 78(9):2205-2218. PubMed ID: 29438990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone acetyl transferase (HAT) HBO1 and JADE1 in epithelial cell regeneration.
    Havasi A; Haegele JA; Gall JM; Blackmon S; Ichimura T; Bonegio RG; Panchenko MV
    Am J Pathol; 2013 Jan; 182(1):152-62. PubMed ID: 23159946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
    Linder A; Larsson K; Welén K; Damber JE
    Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.